P2RY12 and heart failure: Consequently, the use of aspirin, P2Y12 inhibitors, and statins in patients after MICS (55%, 11%, and 47%, respectively) was significantly lower compared to patients after OHS (82%, 27%, and 71%, respectively) There were no differences with regard to heart failure, LVEF, family status, employment status, or living area.